Clinical Trials Directory

Trials / Unknown

UnknownNCT00526006

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Zealand University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The acid secretion in the stomach seems to increase after withdrawal of min. 8 wks of treatment with a PPI (protonpump inhibitor) It is unknown if this acid rebound phenomenon is of clinical significance. In a doubleblinded and placebocontrolled study healthy volunteers are randomized to treatment with placebo or PPI + placebo. Gastrointestinal symptoms are scored once a week and.

Conditions

Interventions

TypeNameDescription
DRUGesomeprazole40 mg od for 8 wks

Timeline

Start date
2007-09-01
Completion
2008-03-01
First posted
2007-09-06
Last updated
2007-09-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00526006. Inclusion in this directory is not an endorsement.